JEFFREY AMBINDER MD NPI 1225142656

NPI Details

Jeffrey Ambinder, MD is a hematology and oncology internal medicine in Yorktown Heights, NY with 51 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. Jeffrey Ambinder, MD NPI is 1225142656. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: NEW YORK UNIVERSITY SCHOOL OF MEDICINE
Graduation Year:1975

The provider's business location address is:

2649 STRANG BLVD
SUITE 208
YORKTOWN HEIGHTS, NY
ZIP 10598-939
Phone: (914) 245-6000
Fax: (914) 245-1675

The NPI 1225142656 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
• Injection, iron sucrose, 1 mg (HCPCS:J1756)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Magnesium level (HCPCS:83735)
• Glutamyltransferase (liver enzyme) level (HCPCS:82977)
• Phosphate level (HCPCS:84100)
• Uric acid level, blood (HCPCS:84550)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Ferritin (blood protein) level (HCPCS:82728)
• Transferrin (iron binding protein) level (HCPCS:84466)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Folic acid level, serum (HCPCS:82746)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Thyroid hormone, t3 measurement, total (HCPCS:84480)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Injection, pegfilgrastim-bmez, biosimilar, (ziextenzo), 0.5 mg (HCPCS:Q5120)
• Nephelometry, test method using light (HCPCS:83883)
• Microsomal antibodies (autoantibody) measurement (HCPCS:86376)
• Thyroglobulin (thyroid protein) antibody measurement (HCPCS:86800)
• Beta-2 microglobulin (protein) level (HCPCS:82232)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)
• Flow cytometry technique for dna or cell analysis, each additional marker (HCPCS:88185)
• Protein measurement, serum (HCPCS:84165)
• Measurement of antibody for assessment of autoimmune disorder, any method (HCPCS:86235)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 125 (HCPCS:86304)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Vitamin d-3 level (HCPCS:82306)
• Parathormone (parathyroid hormone) level (HCPCS:83970)
• Haptoglobin (serum protein) level (HCPCS:83010)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)
• Rheumatoid factor level (HCPCS:86431)
• Measurement of dna antibody, native or double stranded (HCPCS:86225)
• Screening test for autoimmune disorder (HCPCS:86038)
• Drawing of blood for a medical problem (HCPCS:99195)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Flow cytometry technique for dna or cell analysis, first marker (HCPCS:88184)
• Iron level (HCPCS:83540)
• Iron binding capacity (HCPCS:83550)

The enumeration date for this NPI number is 8/19/2006 and was last updated on 10/2/2012.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.